2024-07-012025-03-312025-03-31false06504178DR WAYNE HIRSCHOWITZ LIMITED2025-12-31falseiso4217:GBPxbrli:pure065041782024-06-30065041782025-03-31065041782024-07-012025-03-31065041782023-06-30065041782024-06-30065041782023-07-012024-06-3006504178bus:SmallEntities2024-07-012025-03-3106504178bus:AuditExempt-NoAccountantsReport2024-07-012025-03-3106504178bus:FullAccounts2024-07-012025-03-3106504178bus:PrivateLimitedCompanyLtd2024-07-012025-03-3106504178core:WithinOneYear2025-03-3106504178core:AfterOneYear2025-03-3106504178core:WithinOneYear2024-06-3006504178core:AfterOneYear2024-06-3006504178core:ShareCapital2025-03-3106504178core:SharePremium2025-03-3106504178core:RevaluationReserve2025-03-3106504178core:OtherReservesSubtotal2025-03-3106504178core:RetainedEarningsAccumulatedLosses2025-03-3106504178core:ShareCapital2024-06-3006504178core:SharePremium2024-06-3006504178core:RevaluationReserve2024-06-3006504178core:OtherReservesSubtotal2024-06-3006504178core:RetainedEarningsAccumulatedLosses2024-06-3006504178core:LandBuildings2025-03-3106504178core:PlantMachinery2025-03-3106504178core:Vehicles2025-03-3106504178core:FurnitureFittings2025-03-3106504178core:OfficeEquipment2025-03-3106504178core:NetGoodwill2025-03-3106504178core:IntangibleAssetsOtherThanGoodwill2025-03-3106504178core:ListedExchangeTraded2025-03-3106504178core:UnlistedNon-exchangeTraded2025-03-3106504178core:LandBuildings2024-06-3006504178core:PlantMachinery2024-06-3006504178core:Vehicles2024-06-3006504178core:FurnitureFittings2024-06-3006504178core:OfficeEquipment2024-06-3006504178core:NetGoodwill2024-06-3006504178core:IntangibleAssetsOtherThanGoodwill2024-06-3006504178core:ListedExchangeTraded2024-06-3006504178core:UnlistedNon-exchangeTraded2024-06-3006504178core:LandBuildings2024-07-012025-03-3106504178core:PlantMachinery2024-07-012025-03-3106504178core:Vehicles2024-07-012025-03-3106504178core:FurnitureFittings2024-07-012025-03-3106504178core:OfficeEquipment2024-07-012025-03-3106504178core:NetGoodwill2024-07-012025-03-3106504178core:IntangibleAssetsOtherThanGoodwill2024-07-012025-03-3106504178core:ListedExchangeTraded2024-07-012025-03-3106504178core:UnlistedNon-exchangeTraded2024-07-012025-03-3106504178core:MoreThanFiveYears2024-07-012025-03-3106504178core:Non-currentFinancialInstruments2025-03-3106504178core:Non-currentFinancialInstruments2024-06-3006504178dpl:CostSales2024-07-012025-03-3106504178dpl:DistributionCosts2024-07-012025-03-3106504178core:LandBuildings2024-07-012025-03-3106504178core:PlantMachinery2024-07-012025-03-3106504178core:Vehicles2024-07-012025-03-3106504178core:FurnitureFittings2024-07-012025-03-3106504178core:OfficeEquipment2024-07-012025-03-3106504178dpl:AdministrativeExpenses2024-07-012025-03-3106504178core:NetGoodwill2024-07-012025-03-3106504178core:IntangibleAssetsOtherThanGoodwill2024-07-012025-03-3106504178dpl:GroupUndertakings2024-07-012025-03-3106504178dpl:ParticipatingInterests2024-07-012025-03-3106504178dpl:GroupUndertakingscore:ListedExchangeTraded2024-07-012025-03-3106504178core:ListedExchangeTraded2024-07-012025-03-3106504178dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-07-012025-03-3106504178core:UnlistedNon-exchangeTraded2024-07-012025-03-3106504178dpl:CostSales2023-07-012024-06-3006504178dpl:DistributionCosts2023-07-012024-06-3006504178core:LandBuildings2023-07-012024-06-3006504178core:PlantMachinery2023-07-012024-06-3006504178core:Vehicles2023-07-012024-06-3006504178core:FurnitureFittings2023-07-012024-06-3006504178core:OfficeEquipment2023-07-012024-06-3006504178dpl:AdministrativeExpenses2023-07-012024-06-3006504178core:NetGoodwill2023-07-012024-06-3006504178core:IntangibleAssetsOtherThanGoodwill2023-07-012024-06-3006504178dpl:GroupUndertakings2023-07-012024-06-3006504178dpl:ParticipatingInterests2023-07-012024-06-3006504178dpl:GroupUndertakingscore:ListedExchangeTraded2023-07-012024-06-3006504178core:ListedExchangeTraded2023-07-012024-06-3006504178dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-07-012024-06-3006504178core:UnlistedNon-exchangeTraded2023-07-012024-06-3006504178core:NetGoodwill2025-03-3106504178core:IntangibleAssetsOtherThanGoodwill2025-03-3106504178core:LandBuildings2025-03-3106504178core:PlantMachinery2025-03-3106504178core:Vehicles2025-03-3106504178core:FurnitureFittings2025-03-3106504178core:OfficeEquipment2025-03-3106504178core:AfterOneYear2025-03-3106504178core:WithinOneYear2025-03-3106504178core:ListedExchangeTraded2025-03-3106504178core:UnlistedNon-exchangeTraded2025-03-3106504178core:ShareCapital2025-03-3106504178core:SharePremium2025-03-3106504178core:RevaluationReserve2025-03-3106504178core:OtherReservesSubtotal2025-03-3106504178core:RetainedEarningsAccumulatedLosses2025-03-3106504178core:NetGoodwill2024-06-3006504178core:IntangibleAssetsOtherThanGoodwill2024-06-3006504178core:LandBuildings2024-06-3006504178core:PlantMachinery2024-06-3006504178core:Vehicles2024-06-3006504178core:FurnitureFittings2024-06-3006504178core:OfficeEquipment2024-06-3006504178core:AfterOneYear2024-06-3006504178core:WithinOneYear2024-06-3006504178core:ListedExchangeTraded2024-06-3006504178core:UnlistedNon-exchangeTraded2024-06-3006504178core:ShareCapital2024-06-3006504178core:SharePremium2024-06-3006504178core:RevaluationReserve2024-06-3006504178core:OtherReservesSubtotal2024-06-3006504178core:RetainedEarningsAccumulatedLosses2024-06-3006504178core:NetGoodwill2023-06-3006504178core:IntangibleAssetsOtherThanGoodwill2023-06-3006504178core:LandBuildings2023-06-3006504178core:PlantMachinery2023-06-3006504178core:Vehicles2023-06-3006504178core:FurnitureFittings2023-06-3006504178core:OfficeEquipment2023-06-3006504178core:AfterOneYear2023-06-3006504178core:WithinOneYear2023-06-3006504178core:ListedExchangeTraded2023-06-3006504178core:UnlistedNon-exchangeTraded2023-06-3006504178core:ShareCapital2023-06-3006504178core:SharePremium2023-06-3006504178core:RevaluationReserve2023-06-3006504178core:OtherReservesSubtotal2023-06-3006504178core:RetainedEarningsAccumulatedLosses2023-06-3006504178core:AfterOneYear2024-07-012025-03-3106504178core:WithinOneYear2024-07-012025-03-3106504178core:Non-currentFinancialInstrumentscore:CostValuation2024-07-012025-03-3106504178core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-07-012025-03-3106504178core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-07-012025-03-3106504178core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-07-012025-03-3106504178core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-07-012025-03-3106504178core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-07-012025-03-3106504178core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-07-012025-03-3106504178core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-07-012025-03-3106504178core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-07-012025-03-3106504178core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3106504178core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3106504178core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3106504178core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3106504178core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3106504178core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3106504178core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3106504178core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3106504178core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3106504178core:Non-currentFinancialInstrumentscore:CostValuation2024-06-3006504178core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-06-3006504178core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-06-3006504178core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-06-3006504178core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-06-3006504178core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-06-3006504178core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-06-3006504178core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-06-3006504178core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-06-3006504178bus:Director12024-07-012025-03-31065041781bus:Director12024-06-30065041781bus:Director12024-07-012025-03-31065041781bus:Director12025-03-31065041782024-06-30065041782024-07-012025-03-31065041782025-03-31

DR WAYNE HIRSCHOWITZ LIMITED

Registered Number
06504178
(England and Wales)

Unaudited Financial Statements for the Period ended
31 March 2025

DR WAYNE HIRSCHOWITZ LIMITED
Company Information
for the period from 1 July 2024 to 31 March 2025

Director

HIRSCHOWITZ, Wayne Kevin, Dr

Company Secretary

HIRSCHOWITZ, Estelle Rhoda

Registered Address

136-138 High Street
Esher
KT10 9QJ

Registered Number

06504178 (England and Wales)
DR WAYNE HIRSCHOWITZ LIMITED
Balance Sheet as at
31 March 2025

Notes

31 Mar 2025

30 Jun 2024

£

£

£

£

Fixed assets
Tangible assets31,2124,593
1,2124,593
Current assets
Debtors45,10073,170
Cash at bank and on hand2,133615
7,23373,785
Creditors amounts falling due within one year5(12,084)(62,634)
Net current assets (liabilities)(4,851)11,151
Total assets less current liabilities(3,639)15,744
Creditors amounts falling due after one year6(6,141)(12,080)
Net assets(9,780)3,664
Capital and reserves
Called up share capital100100
Profit and loss account(9,880)3,564
Shareholders' funds(9,780)3,664
The financial statements were approved and authorised for issue by the Director on 31 December 2025, and are signed on its behalf by:
HIRSCHOWITZ, Wayne Kevin, Dr
Director
Registered Company No. 06504178
DR WAYNE HIRSCHOWITZ LIMITED
Notes to the Financial Statements
for the period ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number is 06504178 and registered office address is 136-138 High Street, Esher, Surrey, England, KT10 9QJ.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
The company meets its day-to-day working capital requirements through the continued financial support of its director.
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The critical judgements made by management that have a significant effect on the amounts recognised in the financial statements are described below.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from rendering of services
Revenue from the rendering of dental services is recognised by reference to the stage of completion at the reporting date. This is typically determined based on the date the service is performed. For longer-term treatment plans, revenue is recognised based on the proportion of services delivered up to the reporting date, where the outcome can be reliably estimated. Where the outcome of a course of treatment cannot be estimated reliably, revenue is recognised only to the extent that the expenses incurred are recoverable. As the company is not registered for VAT, revenue is stated inclusive of any VAT charged to patients.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:
Impairment of non-financial assets policy
Assets which are not carried at fair value are reviewed for evidence of impairment at each reporting date. Where the asset is showing indicators of impairment, the recoverable amount of the asset, is estimated and then compared to the carrying value in the financial statements. Where the carrying amount is in excess of recoverable amount, an impairment loss is recognised in profit or loss.
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
2.Average number of employees

20252024
Average number of employees during the year11
3.Tangible fixed assets

Plant & machinery

Total

££
Cost or valuation
At 01 July 2418,08018,080
At 31 March 2518,08018,080
Depreciation and impairment
At 01 July 2413,48713,487
Charge for year3,3813,381
At 31 March 2516,86816,868
Net book value
At 31 March 251,2121,212
At 30 June 244,5934,593
4.Debtors: amounts due within one year

2025

2024

££
Amounts owed by associates and joint ventures / participating interests70071,687
Other debtors4,4001,483
Total5,10073,170
As on period ended 31 March 2025, other debtors comprises of below: Corporation tax recoverable : £1,713.29 (2024: £1,483.46) Directors Loan account : £2,686.21
5.Creditors: amounts due within one year

2025

2024

££
Bank borrowings and overdrafts9,39710,649
Amounts owed to related parties257-
Other creditors2,43051,985
Total12,08462,634
As on period ended 31 March 2025, other creditors comprises of below: Accruals : £2,430.12 ( 2024: £2,340)
6.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts6,14112,080
Total6,14112,080
7.Directors advances, credits and guarantees

Brought forward

Amount advanced

Amount repaid

Carried forward

££££
HIRSCHOWITZ, Wayne Kevin, Dr(49,645)169,992117,6612,686
(49,645)169,992117,6612,686
8.Share capital
As at 31 March 2025, the company’s issued and fully paid share capital consisted of ordinary shares with a nominal value of £1 each, amounting to a total of £100. There were no changes in the issued share capital during the year.
9.Related party transactions
As at 31 March 2025, the company had the following balances with associated companies: Edge Dental Care Ltd – Amount owed to intercompany £25.97 (2024: £71,686.77). Linksfield Holdings Ltd – Amount owed by intercompany £700 (2024: nil). Hirschprop Limited- Amount owed to intercompany £230.72 (2024: nil) Active Aligners UK Limited-Amount owed to intercompany £22,282.07 (2024: nil) Directors loan account : As at the year end, the closing director’s loan account shows an overdrawn balance of £2,686.21 (2024 : -49,645).
10.Change in reporting period and impact on comparability
The company has changed its financial year end. The previous financial statements covered the 12-month period ended 30 June 2024, while the current financial statements cover the 9-month period from 1 July 2024 to 31 March 2025. Consequently, the comparative figures for the prior year are not directly comparable with the current period.